Atai Life Sciences Stock Today
| ATAI Stock | USD 1.35 0.11 7.53% |
PerformanceModest
| Odds Of DistressLow
|
ATAI Life is trading at 1.35 as of the 19th of March 2025. This is a 7.53 percent down since the beginning of the trading day. The stock's open price was 1.46. ATAI Life has less than a 10 % chance of experiencing some financial distress in the next two years of operation, but did not have a good performance during the last 90 trading days. The performance scores are derived for the period starting the 19th of December 2024 and ending today, the 19th of March 2025. Click here to learn more.
Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. Atai Life Sciences N.V. was founded in 2018 and is headquartered in Berlin, Germany. Atai Life operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. The company has 193.99 M outstanding shares of which 11.16 M shares are presently shorted by private and institutional investors with about 2.38 trading days to cover. More on ATAI Life Sciences
Moving together with ATAI Stock
Moving against ATAI Stock
ATAI Stock Highlights
ATAI Life Sciences (ATAI) is traded on NASDAQ Exchange in USA. It is located in Wallstrasse 16, Berlin, Germany, 10179 and employs 83 people. ATAI Life is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 283.23 M. ATAI Life Sciences conducts business under Biotechnology sector and is part of Health Care industry. The entity has 193.99 M outstanding shares of which 11.16 M shares are presently shorted by private and institutional investors with about 2.38 trading days to cover.
ATAI Life Sciences currently holds about 304.06 M in cash with (82.44 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.83, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check ATAI Life Probability Of Bankruptcy
Ownership AllocationATAI Life Sciences secures a total of 193.99 Million outstanding shares. 30% of ATAI Life Sciences outstanding shares are owned by institutions. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Thereupon, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company retains, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check ATAI Ownership Details
ATAI Life Sciences Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. ATAI Life market risk premium is the additional return an investor will receive from holding ATAI Life long position in a well-diversified portfolio.
| Risk Adjusted Performance | 0.0651 | |||
| Jensen Alpha | 0.6495 | |||
| Total Risk Alpha | 1.26 | |||
| Sortino Ratio | 0.0811 |
ATAI Stock Against Markets
ATAI Life Corporate Management
| Ryan Barrett | General VP | Profile | |
| Ryan JD | General Secretary | Profile | |
| Rolando MD | Chief Officer | Profile | |
| Stephen Bardin | Advisor | Profile | |
| Michael Raven | Senior Operations | Profile | |
| Madison Crawford | Sr Accounting | Profile | |
| Glenn Short | Senior Development | Profile |
Already Invested in ATAI Life Sciences?
The danger of trading ATAI Life Sciences is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of ATAI Life is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than ATAI Life. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile ATAI Life Sciences is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether ATAI Life Sciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of ATAI Life's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Atai Life Sciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Atai Life Sciences Stock: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in ATAI Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ATAI Life. If investors know ATAI will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ATAI Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of ATAI Life Sciences is measured differently than its book value, which is the value of ATAI that is recorded on the company's balance sheet. Investors also form their own opinion of ATAI Life's value that differs from its market value or its book value, called intrinsic value, which is ATAI Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ATAI Life's market value can be influenced by many factors that don't directly affect ATAI Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ATAI Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if ATAI Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ATAI Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.